Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines

By Twomey T.   Newman J.   Burrage T.   Piatti P.   Lubroth J.   Brown F.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1603-1610

Elsevier

Access to resources Recommend Favorite

Inactivation of viruses by aziridines

By Brown F.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 322-327

Elsevier

Access to resources Recommend Favorite

Integrity of GH-loop of foot-and-mouth disease virus during virus inactivation: detection by epitope specific antibodies

By Patil P.K.   Suryanarayana V.   Bist P.   Bayry J.   Natarajan C.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1163-1168

Elsevier

Access to resources Recommend Favorite

Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA

By Mackay D.K.J.   Forsyth M.A.   Davies P.R.   Berlinzani A.   Belsham G.J.   Flint M.   Ryan M.D.  

Vaccine, Vol. 16, Iss. 5, 1998-03 ,pp. : 446-459

Elsevier

Access to resources Recommend Favorite

A review of emergency foot-and-mouth disease (FMD) vaccines

By Barnett P.V.   Carabin H.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1505-1514

Elsevier

Access to resources Recommend Favorite